These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35753316)

  • 1. Efficacy of RTS,S/AS01
    Samuels AM; Ansong D; Kariuki SK; Adjei S; Bollaerts A; Ockenhouse C; Westercamp N; Lee CK; Schuerman L; Bii DK; Osei-Tutu L; Oneko M; Lievens M; Attobrah Sarfo MA; Atieno C; Morelle D; Bakari A; Sang T; Jongert E; Kotoh-Mortty MF; Otieno K; Roman F; Buabeng PBY; Ntiamoah Y; Ofori-Anyinam O; Agbenyega T;
    Lancet Infect Dis; 2022 Sep; 22(9):1329-1342. PubMed ID: 35753316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine.
    Westercamp N; Osei-Tutu L; Schuerman L; Kariuki SK; Bollaerts A; Lee CK; Samuels AM; Ockenhouse C; Bii DK; Adjei S; Oneko M; Lievens M; Attobrah Sarfo MA; Atieno C; Bakari A; Sang T; Kotoh-Mortty MF; Otieno K; Roman F; Buabeng PBY; Ntiamoah Y; Ansong D; Agbenyega T; Ofori-Anyinam O
    J Infect Dis; 2024 Aug; 230(2):e486-e495. PubMed ID: 38438123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic analysis of RTS,S/AS01
    Juraska M; Early AM; Li L; Schaffner SF; Lievens M; Khorgade A; Simpkins B; Hejazi NS; Benkeser D; Wang Q; Mercer LD; Adjei S; Agbenyega T; Anderson S; Ansong D; Bii DK; Buabeng PBY; English S; Fitzgerald N; Grimsby J; Kariuki SK; Otieno K; Roman F; Samuels AM; Westercamp N; Ockenhouse CF; Ofori-Anyinam O; Lee CK; MacInnis BL; Wirth DF; Gilbert PB; Neafsey DE
    Lancet Infect Dis; 2024 Sep; 24(9):1025-1036. PubMed ID: 38723650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
    Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
    Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial.
    Otieno L; Oneko M; Otieno W; Abuodha J; Owino E; Odero C; Mendoza YG; Andagalu B; Awino N; Ivinson K; Heerwegh D; Otsyula N; Oziemkowska M; Usuf EA; Otieno A; Otieno K; Leboulleux D; Leach A; Oyieko J; Slutsker L; Lievens M; Cowden J; Lapierre D; Kariuki S; Ogutu B; Vekemans J; Hamel MJ
    Lancet Infect Dis; 2016 Oct; 16(10):1134-1144. PubMed ID: 27394191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
    Olotu A; Lusingu J; Leach A; Lievens M; Vekemans J; Msham S; Lang T; Gould J; Dubois MC; Jongert E; Vansadia P; Carter T; Njuguna P; Awuondo KO; Malabeja A; Abdul O; Gesase S; Mturi N; Drakeley CJ; Savarese B; Villafana T; Lapierre D; Ballou WR; Cohen J; Lemnge MM; Peshu N; Marsh K; Riley EM; von Seidlein L; Bejon P
    Lancet Infect Dis; 2011 Feb; 11(2):102-9. PubMed ID: 21237715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility, safety, and impact of the RTS,S/AS01
    Asante KP; Mathanga DP; Milligan P; Akech S; Oduro A; Mwapasa V; Moore KA; Kwambai TK; Hamel MJ; Gyan T; Westercamp N; Kapito-Tembo A; Njuguna P; Ansong D; Kariuki S; Mvalo T; Snell P; Schellenberg D; Welega P; Otieno L; Chimala A; Afari EA; Bejon P; Maleta K; Agbenyega T; Snow RW; Zulu M; Chinkhumba J; Samuels AM;
    Lancet; 2024 Apr; 403(10437):1660-1670. PubMed ID: 38583454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.
    RTS,S Clinical Trials Partnership
    Lancet; 2015 Jul; 386(9988):31-45. PubMed ID: 25913272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults.
    Moon JE; Ockenhouse C; Regules JA; Vekemans J; Lee C; Chuang I; Traskine M; Jongert E; Ivinson K; Morelle D; Komisar JL; Lievens M; Sedegah M; Garver LS; Sikaffy AK; Waters NC; Ballou WR; Ofori-Anyinam O;
    J Infect Dis; 2020 Oct; 222(10):1681-1691. PubMed ID: 32687161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal vaccination with RTS,S/AS01
    Dicko A; Ouedraogo JB; Zongo I; Sagara I; Cairns M; Yerbanga RS; Issiaka D; Zoungrana C; Sidibe Y; Tapily A; Nikièma F; Sompougdou F; Sanogo K; Kaya M; Yalcouye H; Dicko OM; Diarra M; Diarra K; Thera I; Haro A; Sienou AA; Traore S; Mahamar A; Dolo A; Kuepfer I; Snell P; Grant J; Webster J; Milligan P; Lee C; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Chandramohan D; Greenwood B
    Lancet Infect Dis; 2024 Jan; 24(1):75-86. PubMed ID: 37625434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
    Lusingu J; Olotu A; Leach A; Lievens M; Vekemans J; Olivier A; Benns S; Olomi R; Msham S; Lang T; Gould J; Hallez K; Guerra Y; Njuguna P; Awuondo KO; Malabeja A; Abdul O; Gesase S; Dekker D; Malle L; Ismael S; Mturi N; Drakeley CJ; Savarese B; Villafana T; Ballou WR; Cohen J; Riley EM; Lemnge MM; Marsh K; Bejon P; von Seidlein L
    PLoS One; 2010 Nov; 5(11):e14090. PubMed ID: 21124768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
    Owusu-Agyei S; Ansong D; Asante K; Kwarteng Owusu S; Owusu R; Wireko Brobby NA; Dosoo D; Osei Akoto A; Osei-Kwakye K; Adjei EA; Boahen KO; Sylverken J; Adjei G; Sambian D; Apanga S; Kayan K; Vekemans J; Ofori-Anyinam O; Leach A; Lievens M; Demoitie MA; Dubois MC; Cohen J; Ballou WR; Savarese B; Chandramohan D; Gyapong JO; Milligan P; Antwi S; Agbenyega T; Greenwood B; Evans J
    PLoS One; 2009 Oct; 4(10):e7302. PubMed ID: 19806184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated Within an Expanded Program on Immunization Regimen: A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi.
    Witte D; Cunliffe NA; Turner AM; Ngulube E; Ofori-Anyinam O; Vekemans J; Chimpeni P; Lievens M; Wilson TP; Njiram'madzi J; Mendoza YG; Leach A
    Pediatr Infect Dis J; 2018 May; 37(5):483-491. PubMed ID: 29432383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial.
    Tinto H; Otieno W; Gesase S; Sorgho H; Otieno L; Liheluka E; Valéa I; Sing'oei V; Malabeja A; Valia D; Wangwe A; Gvozdenovic E; Guerra Mendoza Y; Jongert E; Lievens M; Roman F; Schuerman L; Lusingu J
    Lancet Infect Dis; 2019 Aug; 19(8):821-832. PubMed ID: 31300331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
    Bejon P; Lusingu J; Olotu A; Leach A; Lievens M; Vekemans J; Mshamu S; Lang T; Gould J; Dubois MC; Demoitié MA; Stallaert JF; Vansadia P; Carter T; Njuguna P; Awuondo KO; Malabeja A; Abdul O; Gesase S; Mturi N; Drakeley CJ; Savarese B; Villafana T; Ballou WR; Cohen J; Riley EM; Lemnge MM; Marsh K; von Seidlein L
    N Engl J Med; 2008 Dec; 359(24):2521-32. PubMed ID: 19064627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01
    Moon JE; Greenleaf ME; Regules JA; Debois M; Duncan EH; Sedegah M; Chuang I; Lee CK; Sikaffy AK; Garver LS; Ivinson K; Angov E; Morelle D; Lievens M; Ockenhouse CF; Ngauy V; Ofori-Anyinam O;
    Vaccine; 2021 Oct; 39(43):6398-6406. PubMed ID: 34593270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
    Datoo MS; Natama MH; Somé A; Traoré O; Rouamba T; Bellamy D; Yameogo P; Valia D; Tegneri M; Ouedraogo F; Soma R; Sawadogo S; Sorgho F; Derra K; Rouamba E; Orindi B; Ramos Lopez F; Flaxman A; Cappuccini F; Kailath R; Elias S; Mukhopadhyay E; Noe A; Cairns M; Lawrie A; Roberts R; Valéa I; Sorgho H; Williams N; Glenn G; Fries L; Reimer J; Ewer KJ; Shaligram U; Hill AVS; Tinto H
    Lancet; 2021 May; 397(10287):1809-1818. PubMed ID: 33964223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
    Olotu A; Fegan G; Wambua J; Nyangweso G; Awuondo KO; Leach A; Lievens M; Leboulleux D; Njuguna P; Peshu N; Marsh K; Bejon P
    N Engl J Med; 2013 Mar; 368(12):1111-20. PubMed ID: 23514288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial.
    Datoo MS; Natama HM; Somé A; Bellamy D; Traoré O; Rouamba T; Tahita MC; Ido NFA; Yameogo P; Valia D; Millogo A; Ouedraogo F; Soma R; Sawadogo S; Sorgho F; Derra K; Rouamba E; Ramos-Lopez F; Cairns M; Provstgaard-Morys S; Aboagye J; Lawrie A; Roberts R; Valéa I; Sorgho H; Williams N; Glenn G; Fries L; Reimer J; Ewer KJ; Shaligram U; Hill AVS; Tinto H
    Lancet Infect Dis; 2022 Dec; 22(12):1728-1736. PubMed ID: 36087586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy.
    Juraska M; Early AM; Li L; Schaffner SF; Lievens M; Khorgade A; Simpkins B; Hejazi NS; Benkeser DA; Wang Q; Mercer LD; Adjei S; Agbenyega T; Anderson S; Ansong D; Bii DK; Buabeng PBY; English S; Fitzgerald N; Grimsby J; Kariuki SK; Otieno K; Roman F; Samuels AM; Westercamp N; Ockenhouse CF; Ofori-Anyinam O; Lee CK; MacInnis BL; Wirth DF; Gilbert PB; Neafsey DE
    medRxiv; 2023 Nov; ():. PubMed ID: 38045387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.